THURSDAY, SEPTEMBER 21, 2017

Study finds cultural worldview impacts approach to vaccinating children

New research suggests that despite efforts by health officials, a person's cultural worldview helps to explain much of the opposition to vaccination in the U.S., according to a study published in Risk Analysis. Read More »

North Carolina reports first 2013 infant death from whooping cough

Pertussis Read More »

New Hampshire announces new adult vaccination campaign

The New Hampshire Department of Health and Human Services recently announced the launch of a new vaccination campaign meant to promote conversation between healthcare providers and adult patients. Read More »

NIH co-funded trial to evaluate population-wide testing for HIV treatment

HIV Read More »

"Roadmap for Childhood TB: Towards Zero Deaths" launches

Tuberculosis Read More »

Harrisvaccines awarded swine disease contract from USDA subsidiary

Swine flu Read More »

Experts warn on the rising threat of measles in the U.S.

Measles Read More »

Texas officials call for influenza vaccinations

H1N1 Read More »

Consortium to conduct first hookworm vaccine test in sub-Saharan Africa

Hookworms Read More »

Avahan AIDS initiative prevented estimated 600,000 HIV infections

HIV Read More »

Liver specialists urge hepatitis C screening strategy in Canada

hepatitis C Read More »

ViroCyt launches new product to purify viruses

ViroCyt, LLC, a Denver-based life science company, announced the launch on Tuesday of a rapid virus cleanup system meant to purify viruses in egg- and cell-based systems. Read More »

WHO reports three new suspected WPV1 cases in South Sudan

Polio Read More »

Riyadh Ministry of Health reports three news MERS-CoV cases

The Riyadh Ministry of Health announced the confirmation of three new cases of the novel Middle East Respiratory Syndrome Coronavirus on September 27. Read More »

NovaDigm raises $14 million to support phase 2 trial of NDV-3 vaccine

NovaDigm Therapeutics, a company that develops vaccines for fungal and bacterial infections, announced on Thursday that it has raised $14 million to begin a phase 2 clinical trial of its vulvovaginal candidiasis vaccine NDV-3. Read More »

Equatorial Guinea meets with Sanaria on malaria vaccine trial

Obiang Nguema Mbasogo, the president of Equatorial Guinea, met with representatives of the Sanaria Corporation met last week to discuss progress on an upcoming malaria vaccine trial, the country said on Wednesday. Read More »

CureVac announces collaboration with Janssen on flu vaccine

CureVac, a Tubingen, Germany-based clinical stage biopharmaceutical company, announced a new collaboration on Thursday with Janssen Pharmaceuticals, Inc., to develop a new messenger RNA-based influenza vaccine. Read More »

Lao becomes first GAVI supported country to introduce pneumococcal and cervical cancer vaccines

The GAVI Alliance announced on Wednesday that the Lao People's Democratic Republic became the first country in South East Asia to introduce the pneumococcal vaccine and to begin a demonstration project for the HPV vaccine. Read More »

South Sudan renews commitment to fighting HIV/AIDS

HIV Read More »

Global Fund praises Luxembourg's generous commitment

The Global Fund to Fight AIDS, Tuberculosis and Malaria congratulated Luxembourg on Wednesday for its decision to commit $10.1 million to the fund, making it one of the most generous donors per capita. Read More »